Breast cancer (BC) is a heterogeneous disease that comprises four intrinsic molecular subtypes, Luminal A, Luminal B, Her2-enriched and triple-negative (TNBC) [1,2], each with distinct biological features and clinical behaviors [3,4,5]. Here, ERBB2 is linked to breast carcinoma.